Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. N'-(3-((1s)-1-(2-fluoro-4-biphenylyl)ethyl)-1,2-oxazol-5-yl)-4-morpholinecarboximidamide
2. Smp-114
1. Smp-114
2. 215174-50-8
3. Rimacalib [inn]
4. Cid 10157465
5. Bz76j3n815
6. N'-[3-[(1s)-1-(3-fluoro-4-phenylphenyl)ethyl]-1,2-oxazol-5-yl]morpholine-4-carboximidamide
7. N-(3-((1s)-1-(2-fluorobiphenyl-4-yl)ethyl)-1,2-oxazol-5-yl)morpholine-4-carboximidamide
8. 4-morpholinecarboximidamide, N-(3-((1s)-1-(2-fluoro(1,1'-biphenyl)-4-yl)ethyl)-5-isoxazolyl)-
9. Smp 114
10. Sm-114
11. Unii-bz76j3n815
12. Schembl4179253
13. Chembl2107772
14. Db12571
15. Hy-100779
16. Cs-0020416
17. N'-(3-((1s)-1-(2-fluoro-4-biphenylyl)ethyl)-1,2-oxazol-5-yl)-4-morpholinecarboximidamide
| Molecular Weight | 394.4 g/mol |
|---|---|
| Molecular Formula | C22H23FN4O2 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | 394.18050415 g/mol |
| Monoisotopic Mass | 394.18050415 g/mol |
| Topological Polar Surface Area | 76.9 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 551 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Protein Kinase Inhibitors
Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)
ABOUT THIS PAGE
A Rimacalib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rimacalib, including repackagers and relabelers. The FDA regulates Rimacalib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rimacalib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Rimacalib supplier is an individual or a company that provides Rimacalib active pharmaceutical ingredient (API) or Rimacalib finished formulations upon request. The Rimacalib suppliers may include Rimacalib API manufacturers, exporters, distributors and traders.
click here to find a list of Rimacalib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Rimacalib DMF (Drug Master File) is a document detailing the whole manufacturing process of Rimacalib active pharmaceutical ingredient (API) in detail. Different forms of Rimacalib DMFs exist exist since differing nations have different regulations, such as Rimacalib USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rimacalib DMF submitted to regulatory agencies in the US is known as a USDMF. Rimacalib USDMF includes data on Rimacalib's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rimacalib USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rimacalib suppliers with USDMF on PharmaCompass.
Rimacalib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rimacalib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rimacalib GMP manufacturer or Rimacalib GMP API supplier for your needs.
A Rimacalib CoA (Certificate of Analysis) is a formal document that attests to Rimacalib's compliance with Rimacalib specifications and serves as a tool for batch-level quality control.
Rimacalib CoA mostly includes findings from lab analyses of a specific batch. For each Rimacalib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rimacalib may be tested according to a variety of international standards, such as European Pharmacopoeia (Rimacalib EP), Rimacalib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rimacalib USP).
LOOKING FOR A SUPPLIER?
